These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29189120)

  • 41. Association between interleukin 8-251 T/A and +781 C/T polymorphisms and glioma risk.
    Liu H; Mao P; Xie C; Xie W; Wang M; Jiang H
    Diagn Pathol; 2015 Aug; 10():138. PubMed ID: 26249370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The roles of CD147 in the progression of gliomas.
    Fei F; Li S; Fei Z; Chen Z
    Expert Rev Anticancer Ther; 2015; 15(11):1351-9. PubMed ID: 26414447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell surface receptors in malignant glioma.
    Li YM; Hall WA
    Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination therapy for malignant glioma based on PTEN status.
    Gonzalez J; de Groot J
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1767-79. PubMed ID: 18983237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.
    Lefranc F; Mijatovic T; Mathieu V; Rorive S; Decaestecker C; Debeir O; Brotchi J; Van Ham P; Salmon I; Kiss R
    Clin Cancer Res; 2004 Dec; 10(24):8250-65. PubMed ID: 15623601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GSK1904529A, an insulin-like growth factor-1 receptor inhibitor, inhibits glioma tumor growth, induces apoptosis and inhibits migration.
    Zhou Q; Zhang J; Cui Q; Li X; Gao G; Wang Y; Xu Y; Gao X
    Mol Med Rep; 2015 Sep; 12(3):3381-3385. PubMed ID: 26035416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smoothened is a poor prognosis factor and a potential therapeutic target in glioma.
    Tu Y; Niu M; Xie P; Yue C; Liu N; Qi Z; Gao S; Liu H; Shi Q; Yu R; Liu X
    Sci Rep; 2017 Feb; 7():42630. PubMed ID: 28195165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma.
    Liu E; Wu J; Cao W; Zhang J; Liu W; Jiang X; Zhang X
    J Neurooncol; 2007 Dec; 85(3):263-70. PubMed ID: 17594054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.
    Shimamura T; Husain SR; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.
    Bello L; Lucini V; Giussani C; Carrabba G; Pluderi M; Scaglione F; Tomei G; Villani R; Black PM; Bikfalvi A; Carroll RS
    Neurosurgery; 2003 Jan; 52(1):177-85; discussion 185-6. PubMed ID: 12493116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
    Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
    Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect and mechanism of CXCR4 silencing on metastasis suppression of human glioma U87 cell line.
    Zhu Y; Yang P; Zhang X; Zhang L; Cui G; Wang Q; Lv L; Zhang Y; Xin X; Yan T; Zhao M; Zhang N
    Anat Rec (Hoboken); 2013 Dec; 296(12):1857-64. PubMed ID: 24249397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
    Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
    Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.
    Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY
    Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies to target drugs to gliomas and CNS metastases of solid tumors.
    Milojkovic Kerklaan B; van Tellingen O; Huitema AD; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
    J Neurol; 2016 Mar; 263(3):428-40. PubMed ID: 26477024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In Vitro and In Vivo Preclinical Effects of Type I IFNs on Gliomas.
    Galani V; Papadatos SS; Alexiou G; Galani A; Kyritsis AP
    J Interferon Cytokine Res; 2017 Apr; 37(4):139-146. PubMed ID: 28387596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.
    Vajkoczy P; Menger MD; Goldbrunner R; Ge S; Fong TA; Vollmar B; Schilling L; Ullrich A; Hirth KP; Tonn JC; Schmiedek P; Rempel SA
    Int J Cancer; 2000 Jul; 87(2):261-8. PubMed ID: 10861485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.